Clinical Trials Directory

Trials / Conditions / Recurrent Meningioma

Recurrent Meningioma

9 registered clinical trials studyying Recurrent Meningioma — 5 currently recruiting.

StatusTrialSponsorPhase
SuspendedRYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma
NCT07150806
Joshua PalmerPhase 1 / Phase 2
Suspended68Ga-Dotatate PET and MRI Guided Radiation Dose Escalation for High Risk Meningioma
NCT07353229
Thomas Jefferson UniversityPhase 1
Recruiting177Lu-DOTATATE for Recurrent Meningioma
NCT06326190
European Organisation for Research and Treatment of Cancer - EORTCPhase 2
RecruitingAdjuvant Hypofractionated Stereotactic Radiosurgery for Intermediate-risk Meningioma
NCT06557512
University of California, San FranciscoN/A
Active Not RecruitingStereotactic Radiosurgery and Immunotherapy (Pembrolizumab) for the Treatment of Recurrent Meningioma
NCT04659811
Nancy Ann Oberheim Bush, MDPhase 2
RecruitingLutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
NCT04082520
Mayo ClinicPhase 2
Active Not RecruitingNivolumab and Multi-fraction Stereotactic Radiosurgery With or Without Ipilimumab in Treating Patients With Re
NCT03604978
National Cancer Institute (NCI)Phase 1 / Phase 2
RecruitingOptune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Gra
NCT02847559
Northwestern UniversityPhase 2
RecruitingVismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meni
NCT02523014
Alliance for Clinical Trials in OncologyPhase 2